Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-112.69%Return on Equity
VS
Market
Sector
Industry
History
$ 2.43Close
$ 2 - $ 29.07 52-Week Range
Ticker Information
Ticker
BBLGCompany Name
BONE BIOLOGICS CORPSector
HealthcareIndustry
Medical DevicesExchange
NASDAQBONE BIOLOGICS CORP - Return on Equity Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
BBLG - ROE Historical data
| Date | Shareholders Equity | Net Income Common Stock | Return on Equity |
|---|---|---|---|
| 6/30/2025 | $ 6.6M | $ -7.43M | -112.69% |
| 3/31/2025 | $ 2.91M | $ -7.48M | -256.83% |
| 12/31/2024 | $ 3.48M | $ -7.32M | -210.27% |
| 9/30/2024 | $ 3.79M | $ -7.35M | -193.89% |
| 6/30/2024 | $ 2.91M | $ -5.12M | -175.98% |
| 3/31/2024 | $ 3.67M | $ -6.1M | -166.12% |
| 12/31/2023 | $ 2.91M | $ -8.95M | -307.9% |
| 9/30/2023 | $ 3.79M | $ -6.51M | -171.51% |
| 6/30/2023 | $ 5.69M | $ -5.8M | -101.97% |
| 3/31/2023 | $ 2.77M | $ -4.51M | -162.5% |
Key Performance Insights, Last 5 Years
- BONE BIOLOGICS CORP's latest trailing twelve months (TTM) ROE stands at 0%.
- Over the past 5 years, BONE BIOLOGICS CORP's average ROE has been -135.41%.
- The median ROE for BONE BIOLOGICS CORP during this period was -162.5%
- BONE BIOLOGICS CORP reached its highest ROE over the past 5 years at -24.5%.
- The lowest ROE recorded by BONE BIOLOGICS CORP in the same timeframe -307.9%
Similar metrics to ROE:
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Return on Assets - [Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Return on Invested Capital - [Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].
Definition of Return on Equity
[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].Net Inc. Cmn. / Equity
(=) ROE ROE for BONE BIOLOGICS CORP is calculated as follows: Net Inc. Cmn. [ $ -1.82M ] / Equity [ $ -13.69M ]
(=) ROE [ 0% ] BBLG - Return on Equity, Last 5 years
-307.9%
Minimum
Dec 31, 2023
-24.5%
Maximum
Dec 31, 2021
-135.41%
Average
-162.5%
Median
ROE Benchmark AnalysisMarket
The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.63% with a standard deviation of 22.52%.
The following table provides additional summary stats:
ROE in the Market:
| filtered constituents | 3.13K |
|---|---|
| min | -66.24% |
| max | 73.25% |
| average | 1.63% |
| median | 6.53% |
| std | 22.52% |